Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.61
+0.01 (0.02%)
At close: Sep 12, 2025, 4:00 PM EDT
47.55
-0.06 (-0.13%)
After-hours: Sep 12, 2025, 7:59 PM EDT
Tourmaline Bio Market Cap
Tourmaline Bio has a market cap or net worth of $1.23 billion as of September 12, 2025. Its market cap has increased by 186.36% in one year.
Market Cap
1.23B
Enterprise Value
987.16M
1-Year Change
186.36%
Ranking
Category
Stock Price
$47.61
Market Cap Chart
Since October 20, 2023, Tourmaline Bio's market cap has increased from $221.67M to $1.23B, an increase of 453.18%. That is a compound annual growth rate of 146.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.23B | 135.80% |
| Dec 31, 2024 | 520.03M | -2.33% |
| Dec 29, 2023 | 532.42M | 140.18% |
| Oct 20, 2023 | 221.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |